Pantherna Therapeutics is seeking for diverse types of collaborations with pharmaceutical and biotech companies.

  • The Company plans to partner its inhouse development programs at the pre-clinical or clinical stage.
  • In addition, Pantherna is interested in research collaborations and pre-clinical development agreements with industry partners to extend the applications of Pantherna’s proprietary lipid nanoparticle mRNA expression technology platforms (PTX_LNP®, PTXmRNA®).
  • Pantherna is open to research agreements with academia and biotech that have complementary research interest and corresponding capabilities in selected indications proposed by the respective partner.


Business Development Contact

  • Individuals or organizations interested in exploring potential collaboration opportunities are invited to contact:
    Dr. Klaus Giese, CEO